Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
8.35
0.00 (0.00%)
Feb 6, 2026, 4:00 PM EST - Market closed
Journey Medical Employees
Journey Medical had 41 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
41
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,448,756
Profits / Employee
-$211,293
Market Cap
277.69M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 41 | 0 | - |
| Dec 31, 2023 | 41 | 21 | 105.00% |
| Dec 31, 2022 | 20 | -70 | -77.78% |
| Dec 31, 2021 | 90 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,139 |
| Aurora Cannabis | 1,073 |
| Canopy Growth | 960 |
| Kamada | 420 |
| Lifecore Biomedical | 406 |
| Evolus | 329 |
| Akebia Therapeutics | 181 |
| Aquestive Therapeutics | 142 |
DERM News
- 17 days ago - Journey Medical: Emrosi Is Winning, But The Stock Hasn't Noticed - Seeking Alpha
- 2 months ago - Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology - GlobeNewsWire
- 3 months ago - Journey Medical Corporation (DERM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 3 months ago - Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025 - GlobeNewsWire
- 3 months ago - Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference - GlobeNewsWire
- 4 months ago - Journey Medical Corporation to Participate in October 2025 Investor Conferences - GlobeNewsWire
- 5 months ago - Journey Medical: EMROSI's Ramp Puts Profitability On The Horizon - Seeking Alpha